Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

126.24 -0.23 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2 3 4 5 6 7 8 9
...
97 98 Next >
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
These companies haven't given up on the coronavirus vaccine market. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
7 Top Stock Tips for June 2023
The stock market remains unpredictable and volatile. As such, investors should be aware of the following top stock tips for the second half. 
Via InvestorPlace
7 Stocks That Even Company Insiders are Selling
If insider buying is bullish, what's the best move with stocks insiders are selling? Let's take a look at seven of them and find out. 
Via InvestorPlace
Looking At Moderna's Recent Unusual Options Activity
 
Via Benzinga
What's Going On With Moderna Shares Today?
Moderna Inc (NASDAQ: MRNA) shares are trading higher Wednesday amid reports of a COVID-19 surge in China.  
Via Benzinga
Moderna Inc. (NASDAQ: MRNA) is a Leading Gainer in Tuesday Morning Trading
Via Investor Brand Network
GeoVax's Next-Gen Single Dose COVID-19 Vaccine Shows Promising Results
 
Via Benzinga
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction
(Wednesday market open) Investors seeking distraction from the ticking debt ceiling countdown clock get some this afternoon in the form of Federal Reserve meeting minutes and Nvidia (NASDAQ: NVDA)... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Is Moderna Stock a Buy Now?
The company's post-pandemic plans are slowly taking shape. 
Via The Motley Fool
3 Stocks You'll Be Glad You Bought at These Prices
All of these players look cheap considering their long-term prospects. 
Via The Motley Fool
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
 
Via Benzinga
Looking At Moderna's Recent Unusual Options Activity
 
Via Benzinga
(MRNA) - Analyzing Moderna's Short Interest
 
Via Benzinga
Here's Why I Still Own Alexandria Real Estate Equities
This office owner is not like the rest, which could be a very good thing. 
Via The Motley Fool
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
These biotech companies are swinging for the fences. They may hit homers, they may strike out. But you'll definitely want to watch them. 
Via InvestorPlace
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the 
Via Benzinga
Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023
These headwinds won't impact every single company, but many are affected. 
Via The Motley Fool
Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting
Via ACCESSWIRE
Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%
The big question is whether Moderna can replicate these latest results next quarter. 
Via The Motley Fool
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
Vertex Pharmaceuticals hits record high on strong earnings, FDA approval for cystic fibrosis medication for infants. Analysts recently boosted price targets. 
Via MarketBeat
Exposures Product Safety
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside. 
Via MarketBeat
Exposures Product Safety
3 Magnificent Growth Stocks to Buy to Help Build a Millionaire Portfolio
All three of these stocks look like bargains today. 
Via The Motley Fool
Google CEO Sundar Pichai Predicts That This Profession Will Be Most Revolutionized By AI
AI offers investment opportunities across industries. 
Via The Motley Fool
Ready to Buy the Dip? This Biotech Stock Is a Smart Buy
The company's expertise with messenger RNA technology is widely applicable in healthcare. 
Via The Motley Fool
Could Latecomer Moderna Match Big Pharma Rivals in RSV?
RSV is a key part of Moderna's respiratory vaccine business. 
Via The Motley Fool
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, May 16, 2023: AMD, NKE, MRNA, H, BEEM
Advanced Micro Devices (AMD) - The company will host its annual shareholder meeting this week on Thursday. The event will begin at 12 p.m. EDT. While we know annual shareholder meetings are often 
Via Benzinga
Is Novavax Finally Turning Things Around?
Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious disea 
Via MarketBeat
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9
...
97 98 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.